As a Top Five Player in China's Infant Formula Market, How does A2 Milk Exploit Growth Opportunities?
In recent days, New Zealand's A2 Milk Company announced its performance for the first half of the fiscal year 2023-2024, reporting a total revenue of NZ$812.1 million and an EBITDA of NZ$113.2 million, marking a 3.7% and 5.0% increase respectively compared to the same period in 2023.
The company attributed its positive performance to its growth strategy, particularly in seizing opportunities in the Chinese market. However, with declining birth rates in China, the infant formula industry has shifted from growth to a more stable phase. As more brands enter the A2 protein milk powder market, A2 Milk Company faces challenges in securing its position.
Market Share Growth
Enters China's Top Five Infant Formula Brands
According to the financial report, revenue from China and other Asian regions increased by 16.5% to NZ$549.5 million, with EBITDA growing by 21.9% to NZ$135.9 million. However, revenue from Australia and New Zealand declined by 24.1% to NZ$162.2 million due to distribution strategy adjustments.
A2 Milk's performance growth is closely linked to the Chinese market. China alone accounted for 68% of the company's total sales revenue and over 120% of its EBITDA.
Product-wise, while overall revenue for infant formula increased by 1.5%, revenue from Chinese-labelled products grew by 10.4%. English-labelled products saw a 6.9% decrease in overall revenue but increased by 19.9% in China and other Asian regions. Liquid milk revenue in Australia and the US grew by 1.5% and 7% respectively.
Despite a 13.6% decline in China's infant formula market, revenue from China and other Asian regions grew by 16.5%. A2 Milk's English-labelled formula held a 20.6% market share, with cross-border e-commerce channels accounting for 21.4% of sales.
Since announcing its updated growth strategy, A2 Milk has gained substantial market share in China's infant formula market, with revenue and EBITDA increasing by 34.4% and 82.1% respectively. Sales of Chinese-labelled products increased by 50.7%, propelling A2 Milk into China's top five infant formula brands.
The company adjusted its 2024 revenue growth expectation from "low single digits" to "low to mid-single digits," aiming to continue investing in and expanding its presence in the Chinese market. CEO David Bortolussi emphasised the continuation of their growth strategy and plans to introduce more new products later in the year.
Senior dairy industry analyst Liang Song attributes A2 Milk's sustained growth in China to its channel, price, and quality control strategies, consumer education efforts, and digital marketing initiatives.
In terms of A2 Milk's marketing strategies, the company has faced controversies and penalties for improper marketing practices, including overstated health claims and the use of underage endorsers.
With intensified competition in the existing market, A2 Milk faces challenges in maintaining its position. The emergence of domestic A2 milk powder brands presents both opportunities and threats. While providing consumers with more choices, domestic brands often offer lower prices and better value, posing a challenge to A2 Milk's future growth.
Liang Song is optimistic about its future prospects in the Asia-Pacific region, particularly in China, citing its strong consumer education efforts and the increasing popularity of A2 protein as driving forces. Despite market challenges, A2 Milk remains confident in its ability to succeed.